Jeito Capital leads $67.5 million (€64.4 million[1]) Series B financing in XyloCor Therapeutics to develop Novel Gene Therapy in Cardiovascular Disease

Published on January 7, 2025

no treatment options.” About Jeito Capital Jeito Capital is a global leading Private Equity fund with a patient benefit driven approach

Continue reading on website
Other news

Indian stocks register marginal gains after Monday bloodbath

January 7, 2025
Weak GDP growth, foreign fund outflows, rising food prices, and slow consumption were some of the hurdles, keeping many investors at bay in

Mantle Ridge Releases Video Series Introducing Shareholder Nominees and Outlining Solutions for Challenges and Underperformance at Air Products and Chemicals, Inc.

January 7, 2025
None of Mantle Ridge's affiliated entities is a hedge fund or other investment vehicle with a structurally short-term incentive. Mantle